Prescription Drug Costs Driven By Manufacturer Price Hikes, Not Innovation

A recent study shows the cost of brand-name drugs is rising — not because of expensive new therapies entering the market but because manufacturers are raising prices on existing drugs.
While some new drugs entering the market are driving up prices for consumers, drug companies are also hiking prices on older drugs. Source: Sigrid Olsson

The skyrocketing cost of many prescription drugs in the U.S. can be blamed primarily on price increases, not expensive new therapies or improvements in existing medications as drug companies frequently claim, a new study shows.

, published Monday in the journal,found that the cost of brand-name oral prescription drugs rose more than 9 percent a year from 2008 and 2016, while the annual cost of injectable drugs rose more than

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da NPR

NPR4 min letti
NPR Music's Top 20 Songs Of March
Dua Lipa gave us a disco bop, Code Orange glitched its way through an industrial-metal anthem and Kelsea Ballerini offered a thoughtful country ballad about a divided America.
NPR2 min lettiSociety
Spain's Health Staff Are Catching The Coronavirus As Protective Gear Runs Short
Thousands of medical workers now have COVID-19 in Spain, one of the countries hardest-hit by the disease.
NPR3 min lettiPolitics
Justice Department IG Finds Widespread Problems With FBI's FISA Applications
Investigators haven't been submitting sufficient evidence along with their applications to conduct surveillance in counterterrorism and counterintelligence investigations, a report shows.